Rituximab, Temozolomide, and Methylprednisolone in Treating Patients With Recurrent Primary CNS Non-Hodgkin's Lymphoma

Clinical Trial ID NCT00248534

PubWeight™ 2.15^‹?›

🔗 Visit the ClinicalTrials.gov page for NCT00248534

Top papers